70. The Chairman of the ad hoc Working Group, Dr J. Owusu (Australia) introduced the report and recommendations of the group.
71. The following substances were added to the priority list: cyhalothrin, deltamethrin, eprinomectin, nicarbazin, permethrin, phoxim, procaine penicillin, sarafloxacin and temephos.
72. There was some question whether data will be available for the evaluation of temephos. However, the Committee decided to tentatively add this substance on the priority list pending further information at the next session. The Committee accepted the inclusion of spiramycin (residues in cattle milk) and moxidectin (residues in cattle muscle following single doses and in cattle fat following multiple doses) on the list of substances for consideration by the 48th JEFCA.
73. In relation to the list of substances scheduled for the 50th JECFA the Representative from the European Union objected to the presence of porcine somatotropin on the priority list. It was noted, however, that porcine somatotropin met the criteria for inclusion on the priority list, so it was maintained.
74. In regard to a question concerning the status of furazolidone and nitrofural (nitrofurazone), the Delegation of Brazil noted that these two nitrofuran derivatives had been evaluated at the 40th JECFA meeting, and ADIs were not established. The Committee was informed that further evaluations were not considered in the priority list for these compounds because there was no indication new data were available.
75. The agenda of the forty-eighth meeting of JECFA (February 1997) and the tentative agendas of the fiftieth (February 1998) and fifty-second (February 1999) meetings, based on proposals made by the present Working Group and recommendations for re-evaluation by JECFA, are listed in Appendix VII. Substances scheduled for re-evaluation at the fifty-fourth meeting (February 2000) are also listed. The Appendix also contains substances scheduled for residues evaluation on the basis of discussions under agenda items 7 and 8.
76. The Committee thanked the Working Group and its Chairman for its work and agreed to convene the ad hoc Working Group at its next session under Dr J. Owusu (Australia).
